1. Home
  2. VBNK vs VNDA Comparison

VBNK vs VNDA Comparison

Compare VBNK & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VersaBank

VBNK

VersaBank

HOLD

Current Price

$16.33

Market Cap

499.0M

Sector

Finance

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.08

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VBNK
VNDA
Founded
1980
2002
Country
Canada
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
499.0M
474.0M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
VBNK
VNDA
Price
$16.33
$6.08
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$13.00
$13.63
AVG Volume (30 Days)
42.3K
1.0M
Earning Date
03-04-2026
02-11-2026
Dividend Yield
0.45%
N/A
EPS Growth
N/A
N/A
EPS
0.64
N/A
Revenue
$85,792,576.00
$216,105,000.00
Revenue This Year
$37.01
$12.01
Revenue Next Year
$30.71
$24.28
P/E Ratio
$25.63
N/A
Revenue Growth
7.44
8.72
52 Week Low
$8.51
$3.81
52 Week High
$16.99
$9.60

Technical Indicators

Market Signals
Indicator
VBNK
VNDA
Relative Strength Index (RSI) 56.77 34.52
Support Level $15.88 $6.01
Resistance Level $16.99 $7.65
Average True Range (ATR) 0.37 0.45
MACD -0.05 -0.21
Stochastic Oscillator 41.14 5.01

Price Performance

Historical Comparison
VBNK
VNDA

About VBNK VersaBank

VersaBank is a Schedule I Canadian bank that provides mainly commercial lending and banking services to select niche markets in Canada and the United States. Its products and services include credit assets, deposits, and cybersecurity services through its wholly owned subsidiary. The bank operates through four segments: Digital Banking Canada and Digital Banking USA, both using a business-to-business model with proprietary financial technology to serve underserved markets; DRTC, which provides cybersecurity services and banking and financial technology development; and Digital Meteor, which owns proprietary technology supporting next-generation digital assets, including Real Bank Deposit Tokens (RBDTs). The majority of revenue comes from Digital Banking.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: